Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-EN | Version v5-EN | |
---|---|---|
Language | English | English |
Date Updated | 2017-07-01 | 2017-06-21 |
Drug Identification Number | 02439573 | 02439573 |
Brand name | MINT-RIZATRIPTAN ODT | MINT-RIZATRIPTAN ODT |
Common or Proper name | Rizatriptan Benzoate | Rizatriptan Benzoate |
Company Name | MINT PHARMACEUTICALS INC | MINT PHARMACEUTICALS INC |
Ingredients | RIZATRIPTAN | RIZATRIPTAN |
Strength(s) | 5MG | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL | ORAL |
Packaging size | Blister pack of 6 Tablets | Blister pack of 6 Tablets |
ATC code | N02CC | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS | ANTIMIGRAINE PREPARATIONS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | ||
Actual discontinuation date | 2017-06-30 | 2017-06-30 |
Remaining supply date | 2017-06-30 | 2017-06-30 |
Discontinuation status | Discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | ||
Health Canada comments |